Neogen (NASDAQ:NEOG) Releases Earnings Results, Beats Estimates By $0.12 EPS

Neogen (NASDAQ:NEOG) released its earnings results on Friday. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.12, Briefing.com reports. Neogen had a positive return on equity of 2.80% and a negative net margin of 2.58%. The firm had revenue of $231.30 million during the quarter, compared to the consensus estimate of $227.16 million. During the same quarter in the previous year, the company posted $0.11 earnings per share. The company’s revenue was up .7% compared to the same quarter last year. Neogen updated its FY 2025 guidance to EPS.

Neogen Trading Down 5.4 %

Neogen stock opened at $12.36 on Friday. The company has a current ratio of 4.41, a quick ratio of 2.79 and a debt-to-equity ratio of 0.28. The firm has a market cap of $2.68 billion, a PE ratio of -112.36 and a beta of 1.23. The stock’s 50 day simple moving average is $13.50 and its two-hundred day simple moving average is $15.07. Neogen has a 12 month low of $11.46 and a 12 month high of $18.75.

Analyst Ratings Changes

Several analysts have commented on the stock. StockNews.com upgraded shares of Neogen to a “sell” rating in a research note on Monday, September 30th. Guggenheim initiated coverage on shares of Neogen in a research report on Thursday, December 19th. They set a “buy” rating and a $15.00 target price for the company.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.